Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;48(3):247-54.
doi: 10.4103/0019-5413.132497.

Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors

Neelam Wadhwa  1
Affiliations

Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors

Neelam Wadhwa. Indian J Orthop. 2014 May.

Abstract

Osteosarcoma (OS), the commonest malignancy of osteoarticular origin, is a very aggressive neoplasm. Divergent histologic differentiation is common in OS; hence triple diagnostic approach is essential in all cases. 20% cases are atypical owing to lack of concurrence among clinicoradiologic and pathologic features necessitating resampling. Recognition of specific anatomic and histologic variants is essential in view of better outcome. Traditional prognostic factors of OS do stratify patients for short term outcome, but often fail to predict their long term outcome. Considering the negligible improvement in the patient outcome during the last 20 years, search for novel prognostic factors is in progress like ezrin vascular endothelial growth factor, chemokine receptors, dysregulation of various micro ribonucleic acid are potentially promising. Their utility needs to be validated by long term followup studies before they are incorporated in routine clinical practice.

Keywords: Osteosarcoma; ezrin; prognostic factors; vascular endothelial growth factor.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None.

References

    1. Mirra JM, Gold RH, Picci P. Osseous tumors of intranedullary origin. In: Mirra JM, Picci P, Gold RH, editors. Bone Tumors. Clinical, Radiologic and Pathologic Correlations. Philadelphia: Lea and Febiger Publishers; 1989. pp. 143–438.
    1. Fechner RE, Mills SE. Tumors of the Bones and Joints. Washington DC: Armed Forces Institute of Pathology; 1992. Atlas of Tumor Pathology.
    1. Broadhead ML, Clark JC, Myers DE, Dass CR, Choong PF. The molecular pathogenesis of osteosarcoma: A review. Sarcoma 2011. 2011 959248. - PMC - PubMed
    1. Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer. 2006;106:1154–61. - PubMed
    1. Allison DC, Carney SC, Ahlmann ER, Hendifar A, Chawla S, Fedenko A, et al. A meta-analysis of osteosarcoma outcomes in the modern medical era. Sarcoma 2012. 2012 704872. - PMC - PubMed

LinkOut - more resources